These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 17720626)

  • 1. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
    Luzi G; Diamanti AP; Germano V; Laganà B; Di Rosa R; Salemi S; Stoppacciaro A; D'Amelio R
    Clin Immunol; 2007 Nov; 125(2):127-30. PubMed ID: 17720626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
    Mok MY; Lo Y; Chan TM; Wong WS; Lau CS
    J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual mixed infection of thoracic empyema caused by Mycobacteria tuberculosis, nontuberculosis mycobacteria and Nocardia asteroides in a woman with systemic lupus erythematosus.
    Huang HC; Yu WL; Shieh CC; Cheng KC; Cheng HH
    J Infect; 2007 Jan; 54(1):e25-8. PubMed ID: 16712939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of systemic lupus erythematosus with intravenous human immunoglobulins. Preliminary study].
    Migliaresi S; Gallo M; Tirri G
    Clin Ter; 1992 Sep; 141(9 Pt 2):83-4. PubMed ID: 1468203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute tuberculosis cutis miliaris disseminata in a patient with systemic lupus erythematosus.
    Ko JH; Shih YC; Huang YH; Lu CF; Yang CH
    Int J Dermatol; 2011 Oct; 50(10):1279-82. PubMed ID: 21950297
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of high-dose intravenous immunoglobulins in the therapy of connectivitis: preliminary experience in 5 cases].
    De Vita S; D'Ascanio A; Bombardieri S
    Recenti Prog Med; 1991 Nov; 82(11):603-6. PubMed ID: 1763234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Iliopsoas abscess and systemic lupus erythematosus].
    García Hernández FJ; Sánchez Román J; Ocaña Medina C; Mateos Romero L; Molinillo López J; Wichmann I
    An Med Interna; 2003 Apr; 20(4):198-200. PubMed ID: 12768835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases.
    Winder A; Molad Y; Ostfeld I; Kenet G; Pinkhas J; Sidi Y
    J Rheumatol; 1993 Mar; 20(3):495-8. PubMed ID: 8478856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
    Vina ER; Fang AJ; Wallace DJ; Weisman MH
    Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenously-administered immunoglobulins as first-choice agent in juvenile dermatomyositis].
    Breems DA; de Haas PW; Visscher F; Sabbe LJ; Busch HF; van Doorn PA
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1979-82. PubMed ID: 8413708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus.
    Kadoya A; Okada J; Iikuni Y; Kondo H
    J Rheumatol; 1996 Jul; 23(7):1186-8. PubMed ID: 8823690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside.
    Zandman-Goddard G; Blank M; Shoenfeld Y
    Lupus; 2009 Sep; 18(10):884-8. PubMed ID: 19671787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases.
    Sherer Y; Kuechler S; Jose Scali J; Rovensky J; Levy Y; Zandman-Goddard G; Shoenfeld Y
    Isr Med Assoc J; 2008 Jan; 10(1):55-7. PubMed ID: 18300575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic epidermal necrolysis in systemic lupus erythematosus.
    Horne NS; Narayan AR; Young RM; Frieri M
    Autoimmun Rev; 2006 Feb; 5(2):160-4. PubMed ID: 16431352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis in patients with systemic lupus erythematosus.
    Balakrishnan C; Mangat G; Mittal G; Joshi VR
    J Assoc Physicians India; 1998 Aug; 46(8):682-3. PubMed ID: 11229272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of reactive hemophagocytic syndrome in systemic lupus erythematosus.
    Papo T; Andre MH; Amoura Z; Lortholary O; Tribout B; Guillevin L; Piette JC
    J Rheumatol; 1999 Apr; 26(4):927-30. PubMed ID: 10229419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin therapy: magic or black magic.
    Barron KS; Sher MR; Silverman ED
    J Rheumatol Suppl; 1992 Apr; 33():94-7. PubMed ID: 1593608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of Evans syndrome combined with systemic lupus erythematosus successfully treated with rituximab.
    Kittaka K; Dobashi H; Baba N; Iseki K; Kameda T; Susaki K; Kitanaka A; Kubota Y; Ishida T
    Scand J Rheumatol; 2008; 37(5):390-3. PubMed ID: 18609263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.
    Toubi E; Kessel A; Shoenfeld Y
    Hum Immunol; 2005 Apr; 66(4):395-402. PubMed ID: 15866703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High dose intravenous immunoglobulins in treating systemic lupus erythematosus-associated thrombocytopenia].
    Zhang X; Dong Y; Tang F; Zhang F; Li H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):82-4. PubMed ID: 12903501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.